These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 7912179

  • 1. [The treatment of ulcerative colitis].
    Turunen U, Järvinen HJ.
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract] [Full Text] [Related]

  • 2. [Current medical treatment of hemorrhagic rectocolitis].
    Gendre JP.
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T9-12. PubMed ID: 7913901
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Current orientation in medical management of ulcerative colitis].
    Grassi M, Raffa S, Damiani VC, Fontana M.
    Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of ulcerative colitis: the Indian perspective.
    Anand AC, Singh W.
    Trop Gastroenterol; 1991 May; 12(3):108-18. PubMed ID: 1688144
    [No Abstract] [Full Text] [Related]

  • 7. Comment: mesalamine in ulcerative colitis.
    Rothbart D.
    DICP; 1991 Sep; 25(9):1015-6. PubMed ID: 1683077
    [No Abstract] [Full Text] [Related]

  • 8. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug 21; 34(877):80-1. PubMed ID: 1353858
    [No Abstract] [Full Text] [Related]

  • 9. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 10. [Salazosulfapyridine or 5-aminosalicylic acid].
    van Hees PA.
    Ned Tijdschr Geneeskd; 1987 May 30; 131(22):931-4. PubMed ID: 2885762
    [No Abstract] [Full Text] [Related]

  • 11. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 30; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H.
    Internist (Berl); 1987 Jan 30; 28(1):14-20. PubMed ID: 2883152
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov 30; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 15. Will there be a next generation of sulfasalazine?
    Goldman P.
    Gastroenterology; 1982 Nov 30; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract] [Full Text] [Related]

  • 16. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK, Irvine EJ.
    Am J Gastroenterol; 2000 Jul 30; 95(7):1628-36. PubMed ID: 10925961
    [Abstract] [Full Text] [Related]

  • 17. [Drug therapy of ulcerative colitis].
    Rückert Y.
    Z Arztl Fortbild Qualitatssich; 1997 Mar 30; 91(2):175-9. PubMed ID: 9244661
    [Abstract] [Full Text] [Related]

  • 18. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE, Kane S.
    Rev Gastroenterol Disord; 2004 Mar 30; 4(2):86-91. PubMed ID: 15185719
    [Abstract] [Full Text] [Related]

  • 19. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP.
    Dtsch Med Wochenschr; 1992 Oct 16; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract] [Full Text] [Related]

  • 20. [Ulcerative colitis. Acute episode].
    Reissmann A, Bischoff SC, Fleig W.
    Z Gastroenterol; 2004 Sep 16; 42(9):994-8. PubMed ID: 15455271
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.